Evidence map›Paper›PMID 41890515›Full record

ArticleAnnals of surgery open : perspectives of surgical history, education, and clinical approaches2026

Variation in the Surgical Care of Early Stage Melanoma Based on Surgical Subspecialty: Evaluation of Large Healthcare System.

Kristel Lourdault, Arthur W Cowman, Emiliano Reyes, Danny Lascano, Udai S Sibia, Brett Crosby, Tyler Aguilar, Deanna Rider, Stacey Stern, Richard Essner

Abstract read
In one paragraph

Article in Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristel LourdaultFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Arthur W CowmanFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Emiliano ReyesFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Danny LascanoFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Udai S SibiaFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Brett CrosbyFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Tyler AguilarFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Deanna RiderProvidence Research Network, Providence Health System, Missoula, MT.
Stacey SternFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.
Richard EssnerFrom the Saint John's Cancer Institute, Providence Health & Services, Division of Surgical Oncology, Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate how different surgeons' subspecialties comply with treatment guidelines for early stage melanoma. Background: The National Comprehensive Cancer Network developed evidence-based guidelines for surgical margins, depth of excision, and performance of sentinel lymph node biopsy (SLNB) for cutaneous melanoma care. It is unknown how surgeons of varying subspecialties follow these guidelines. Methods: We included patients with primary cutaneous melanoma who underwent wide excision (WE) in 2022 across our healthcare system. We collected patients' clinicopathological characteristics, margin size, and depth of the WE, those who underwent SLNB and the treating surgeon's subspecialty. Results: Among 838 patients, 58.8% had T1 melanoma, 22.2% T2, and 18.9% T3-T4. Surgical oncologists (SO) performed most procedures (56.4%) followed by general surgeons (GS, 20.1%), dermatologists (Derm, 13.5%), otolaryngologists (ENT, 5.4%), and plastic surgeons (PS, 4.7%). Compliance with the recommended surgical margin size was highest for T1 (81.7%) and T2 (92.6%) compared to T3-T4 stages (64.2%; Conclusions: Overall compliance with surgical margin size and excision depth was 80.8% and 84.8%, respectively. In our study, 93% of eligible patients underwent SLNB. Despite overall high compliance rates, we noted large differences in guideline compliance among the surgeons' subspecialty.

Indexed as

melanomaNational Comprehensive Cancer Networksentinel lymph node biopsysurgical margin sizewide excision

Identifiers

PMID41890515
PMCPMC13016181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.